我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
隶属于 PFIZER INC.
相关临床试验
3
2 进行中
药物批准
419
批准总数
监管机构
2
监管机构数
成立时间
2004
进行中（未招募）
66.7%
已完成
1
33.3%
FDA
Food and Drug Administration
413
PHILIPPINES
Philippines FDA
6
- Gland Pharma has secured US FDA approval for its phytonadione injectable emulsion, a generic version of vitamin K1 injectable emulsion. - The drug is indicated for treating coagulation disorders resulting from vitamin K deficiency or interference with vitamin K activity. - The company plans to launch the product through its marketing partners, with US sales for the reference drug estimated at $15 million annually. - Gland Pharma's stock experienced a rally following the announcement, reflecting positive market sentiment.
